Skip to content
OpenCapital
Get started

InfuSystem Holdings INFU Cash & Equivalents

Cash & Equivalents at other companies

Baxter International logo
Baxter InternationalBAX
$2.02B-12.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.02B+49.0%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$177.32M+3.5%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$9.76M-3.9%
UFP Technologies logo
UFP TechnologiesUFPT
$19.98M+42.4%
ICU Medical logo
ICU MedicalICUI
$288.33M-0.5%

Other financials

Income statement

See full
Revenue$33.7M-3.0%
Gross profit$19.7M+2.7%
Operating income$1.6M+157%
Net income$1.0M+481%
EPS (diluted)$0.05+600%

Balance sheet

See full
Total debt$24.1M-30.4%
Total equity$58.7M+6.5%
Total assets$98.7M-5.4%

Cash flow

See full
Operating cash flow$970.0K-45.5%
CapEx$157.0K+19.8%
Free cash flow$813.0K-50.7%

Valuation

See full
Market cap$205.05M+51.3%
Enterprise value$227.04M+36.2%
P/E25.9×-0.8×
P/S1.4×+0.5×

Profitability

See full
Gross margin56.7%+3.6pp
Operating margin9.1%+3.0pp
Net margin5.6%+3.2pp
FCF margin16.2%+1.0pp

Returns & leverage

See full
Return on equity13.9%+8.0pp
Debt / equity0.4×-0.2×
Current ratio2.1×-0.1×

Where this comes from

Reported directly by InfuSystem Holdings in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InfuSystem Holdings's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InfuSystem Holdings's cash & equivalents?
InfuSystem Holdings (INFU) reported cash & equivalents of $2.11M in Q1 2026.
How has InfuSystem Holdings's cash & equivalents changed year-over-year?
InfuSystem Holdings's cash & equivalents increased by 39.8% year-over-year, from $1.51M to $2.11M.
What is the long-term trend for InfuSystem Holdings's cash & equivalents?
Over 5 years (2020 to 2025), InfuSystem Holdings's cash & equivalents has grown at a -19.9% compound annual growth rate (CAGR), from $9.65M to $3.19M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.